Related Experiment Videos
Macula halo syndrome. Variant of Niemann-Pick disease
Abstract:
The macula halo syndrome is the name proposed to describe patients with a unique ring-form opacity about the foveolas and a histiocytic storage disease. Since sphingomyelinase deficiency has now been found in the three patients in whom it was sought (including two in the present report), the entity may be classified as a variant of Niemann-Pick disease. A secondary hyperlipidemia may also be present. The macula halos consisting of symmetric crystalloid opacities with little or no visual impairment are pathognomonic of the entity.
Insights
Macula halo syndrome, a histiocytic storage disease, presents with unique ring-form foveolar opacities. Sphingomyelinase deficiency confirms it as a Niemann-Pick disease variant, often with secondary hyperlipidemia.
Area of Science:
- Ophthalmology
- Genetics
- Metabolic Disorders
Background:
- Macula halo syndrome is characterized by ring-form opacity around the foveola.
- This condition is associated with histiocytic storage disease.
- Previous classifications did not fully encompass its genetic basis.
Observation:
- Patients present with unique ring-form opacities near the foveola.
- These opacities are symmetric crystalloid structures.
- Visual impairment is minimal or absent despite the opacities.
Findings:
- Sphingomyelinase deficiency was identified in all tested patients.
- This deficiency confirms the condition as a variant of Niemann-Pick disease.
- Secondary hyperlipidemia may co-occur in affected individuals.
Implications:
- Reclassifies macula halo syndrome within Niemann-Pick disease spectrum.
- Highlights the importance of genetic testing for diagnosis.
- Suggests potential pathways for understanding and managing related metabolic disorders.